|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | (2006.01) |
| A61K 31/439 | (2013.01) | ||
| A61K 31/137 | (2006.01) | ||
| A61K 31/135 | (2013.01) | ||
| A61K 31/137 | (2013.01) | ||
| A61K 31/138 | (2006.01) | ||
| A61K 38/215 | (2013.01) | ||
| A61K 31/216 | (2006.01) | ||
| A61K 31/40 | (2006.01) | ||
| A61K 31/5415 | (2013.01) | ||
| A61K 31/439 | (2006.01) | ||
| A61K 31/138 | (2013.01) | ||
| A61K 31/46 | (2006.01) | ||
| A61K 31/40 | (2013.01) | ||
| A61K 31/495 | (2006.01) | ||
| A61K 31/216 | (2013.01) | ||
| A61K 31/5415 | (2006.01) | ||
| A61K 31/46 | (2013.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61K 31/495 | (2013.01) | ||
| A61P 25/02 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 25/02 | (2018.01) | ||
| A61P 29/00 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3502236 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18208362.6 |
| Date of filing the European patent application | 2012-02-17 | |
| (97) | Date of publication of the European application | 2019-06-26 |
| (45) | Date of publication and mention of the grant of the patent | 2023-08-23 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201161444666 P | 2011-02-18 | US |
| (72) |
SCHULTZ, Peter , US
LAIRSON, Luke , US
DESHMUKH, Vishal , US
LYSSIOTIS, Costas , US
|
| (73) |
The Scripps Research Institute ,
Mail Drop TPC-8
10550 North Torrey Pines Road, La Jolla CA 92037,
US
Novartis AG , Lichtstrasse 35, 4056 Basel, CH |
| (54) | DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE |
| DIRECTED DIFFERENTIATION OF OLIGODENDROCYTE PRECURSOR CELLS TO A MYELINATING CELL FATE |